Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
Bone Marrow Transplantation
|
March 22, 2005
Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation
A Spencer, N Horvath, J Gibson, et al.
Bone Marrow Transplantation
|
March 14, 2003
Successful mobilization of peripheral blood stem cells after addition of ancestim (stem cell factor) in patients who had failed a prior mobilization with filgrastim (granulocyte colony-stimulating factor) alone or with chemotherapy plus filgrastim
L B To, J Bashford, S Durrant, et al.
Cytotherapy
|
May 15, 2002
Isolex 300i CD34-selected cells to support multiple cycles of high-dose therapy
H M Prince, J Bashford, D Wall, et al.
Leukemia Research
|
March 10, 1999
Safe mobilization of normal progenitors in advanced chronic myeloid leukemia with intensive chemotherapy and granulocyte-colony stimulating factor
J Morton, P Mollee, K Taylor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
Multicycle high-dose chemotherapy and filgrastim-mobilized peripheral-blood progenitor cells in women with high-risk stage II or III breast cancer: five-year follow-up
R L Basser, L B To, J P Collins, et al.
Leukemia
|
August 23, 2001
Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia
K Bradstock, J Matthews, G Young, et al.
British Journal of Haematology
|
October 1, 1996
High response rates with short infusional 2-chlorodeoxyadenosine in de novo and relapsed low-grade lymphoma. Australian and New Zealand Lymphoma Study Group
J Morton, K Taylor, I Bunce, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
Bone Marrow Transplantation
|
March 22, 2005
Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation
A Spencer, N Horvath, J Gibson, et al.
Bone Marrow Transplantation
|
March 14, 2003
Successful mobilization of peripheral blood stem cells after addition of ancestim (stem cell factor) in patients who had failed a prior mobilization with filgrastim (granulocyte colony-stimulating factor) alone or with chemotherapy plus filgrastim
L B To, J Bashford, S Durrant, et al.
Cytotherapy
|
May 15, 2002
Isolex 300i CD34-selected cells to support multiple cycles of high-dose therapy
H M Prince, J Bashford, D Wall, et al.
Leukemia Research
|
March 10, 1999
Safe mobilization of normal progenitors in advanced chronic myeloid leukemia with intensive chemotherapy and granulocyte-colony stimulating factor
J Morton, P Mollee, K Taylor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
Multicycle high-dose chemotherapy and filgrastim-mobilized peripheral-blood progenitor cells in women with high-risk stage II or III breast cancer: five-year follow-up
R L Basser, L B To, J P Collins, et al.
Leukemia
|
August 23, 2001
Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia
K Bradstock, J Matthews, G Young, et al.
British Journal of Haematology
|
October 1, 1996
High response rates with short infusional 2-chlorodeoxyadenosine in de novo and relapsed low-grade lymphoma. Australian and New Zealand Lymphoma Study Group
J Morton, K Taylor, I Bunce, et al.
Page
of 5